Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCL1-AMFR Facilitates Glioblastoma Progression by Modulating the Cross-talk between Glioma Cells and Tumor-Associated Macrophages. | Cancer Immunol Res | 2026 | 41616307 | PubTator, text mining | PubMed |
| Chemokine Networks in Cutaneous T Cell Lymphoma: Tumor Microenvironment Remodeling and Therapeutic Targets. | Curr Issues Mol Biol | 2026 | 41614909 | PubTator, text mining | PubMed |
| Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis. | J Immunother Cancer | 2026 | 41592889 | PubTator, text mining | PubMed |
| Fluorescence tracking Treg movement identifies anti-CCR8 and radiation as a therapeutic combination. | iScience | 2026 | 41585478 | PubTator, text mining | PubMed |
| Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model. | NPJ Syst Biol Appl | 2026 | 41545416 | PubTator, text mining | PubMed |
| <p>Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)</p>. | Oncol Rep | 2026 | 41543186 | PubTator, text mining | PubMed |
| Identification of Comprehensive Landscape of Peripheral Immunity and Chemokine-Related Genes in Amyotrophic Lateral Sclerosis. | Immunotargets Ther | 2026 | 41531792 | PubTator, text mining | PubMed |
| Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials. | J Immunother Cancer | 2026 | 41526165 | PubTator, text mining | PubMed |
| A novel polypeptide molecule attenuates atopic dermatitis by targeting CCR8-CCL1 axis. | Int Immunopharmacol | 2026 | 41455364 | PubTator, text mining | PubMed |
| CHS-114: An Afucosylated Anti-CCR8 Monoclonal Antibody that Selectively Depletes Intratumoral Treg Cells and Induces Antitumor Immune Responses. | Mol Cancer Ther | 2026 | 41423415 | PubTator, text mining | PubMed |
| Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development. | Annu Rev Med | 2026 | 41232570 | PubTator, text mining | PubMed |
| RAP-103, a multi-chemokine receptor antagonist, displays anxiolytic-like effects and normalizes methamphetamine abstinence-induced behaviors in planarians. | Physiol Behav | 2026 | 41192723 | PubTator, text mining | PubMed |
| Integrative multi-omics stratification and translational evaluation of Treg-targeted combination immunotherapy in breast cancer. | Front Oncol | 2025 | 41568381 | PubTator, text mining | PubMed |
| [Guardians of Immune Tolerance: Regulatory T Cells]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536667 | PubTator, text mining | PubMed |
| CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors. | Eur J Immunol | 2025 | 41420480 | PubTator, text mining | PubMed |
| Single-cell analysis indicating CCR8 modulates CD8+ tissue-resident memory T cells to attenuates rejection in transplantation. | Sci Rep | 2025 | 41402575 | PubTator, text mining | PubMed |
| Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial. | Nat Commun | 2025 | 41345127 | PubTator, text mining | PubMed |
| The immunosuppressive role of CCR8+ Tregs in gastric cancer. | J Cancer | 2025 | 41323783 | PubTator, text mining | PubMed |
| The 2025 Nobel Prize in Physiology or Medicine - a bridge to peripheral immune tolerance. | J Clin Invest | 2025 | 41321313 | PubTator, text mining | PubMed |
| Impact of Female Sex Hormones on the Expression of CCR5/CCR8 Co-Receptor Genes and Virus Replication in HIV-1 Infection. | Bull Exp Biol Med | 2025 | 41186821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=3